Drug product development is traditionally being done on a single compound in patients with a single disease or at least strictly randomized and surveyed. This often misses the "real patients" and major user group to which 70 % in volume of our drugs are prescribed to - the patients beyond 65 years.
This webinar will focus on two major areas in the development of age appropriate products:
1. The specific physiological derived needs of older adults
2. Common Issue with medication and dosage form recommendation for older adults
The objective is to draw a basic picture on the real older patients and their needs in complex drug therapy and discuss how this translates into advanced product development and design.
Key Learning Objectives
See the webinar here: